11/28
09:12 am
clgn
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
Medium
Report
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
11/26
08:08 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
Medium
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
11/26
07:30 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Medium
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
11/18
07:00 am
clgn
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
Low
Report
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
10/27
07:01 am
clgn
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
Low
Report
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
10/20
09:53 am
clgn
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
Medium
Report
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
10/20
07:00 am
clgn
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
Medium
Report
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
10/16
07:00 am
clgn
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
Medium
Report
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
10/3
09:12 am
clgn
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year [Yahoo! Finance]
Low
Report
One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year [Yahoo! Finance]
9/30
07:44 am
clgn
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler [Yahoo! Finance]
High
Report
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler [Yahoo! Finance]
9/30
07:00 am
clgn
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
High
Report
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
9/16
08:07 am
clgn
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
Low
Report
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
9/15
07:00 am
clgn
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
Low
Report
CollPlant Expands the Distribution of its VergenixSTR Product in Europe